Sriram Krishnan: 'There will not be an FDA for AI' — outgoing Trump AI adviser on light-touch regulation

Key takeaways from a Financial Times interview with departing White House AI adviser and former Andreessen Horowitz partner Sriram Krishnan (July 2026), his first in-depth interview since leaving the administration:

Read more: Financial Times